| Name | N,N-dimethyl-5-[(4-phenylphenyl)methyl]tetrazole-1-carboxamide |
|---|---|
| Synonyms |
5-[[(1,1'-BIPHENYL)-4-YL]METHYL]-N,N-DIMETHYL-1H-TETRAZOLE-1-CBOXAMIDE
5-(biphenyl-4-ylMethyl)-N,N-diMethyl-1H-tetrazole-1-cboxaMide LY2183240 powder LY2183240/LY-2183240 5-Biphenyl-4-ylmethyl-tetrazole-1-cboxylic acid dimethylamide 1H-Tetrazole-1-cboxamide, 5-([1,1′-biphenyl]-4-ylmethyl)-N,N-dimethyl 5-(4-Biphenylylmethyl)-N,N-dimethyl-1H-tetrazole-1-carboxamide Inhibitor,brain,uptake,transport,hydrolases,Fatty acid amide hydrolase,LY2183240,Autophagy,LY 2183240,serine,anandamide,FAAH,inhibit,LY-2183240 LY-2183240 MN-25 N,N-dimethyl-5-[(4-phenylphenyl)methyl]tetrazole-1-cboxamide 5- ([1,1 '- biphenyl] -4-methyl) - N, N-dimethyl-1H-tetrazol-1-formamide LY-2183240 HMS3269E15 LY2183240, 10 mM in DMSO 1H-Tetrazole-1-carboxamide 5-(Biphenyl-4-ylmethyl)-N,N-dimethyl-1H-tetrazole-1-carboxamide |
| Description | LY2183240 is a novel and highly potent blocker of anandamide uptake (IC50 = 270 pM). LY2183240 inhibits fatty acid amide hydrolase (FAAH) activity (IC50 = 12.4 nM). IC50: 270 pM (anandamide uptake); 12.4 nM (FAAH)Target: FAAH; Anandamide uptakeFollowing i.p. administration in rats, LY2183240 increases brain anandamide concentration and exerts antinociceptive effects in formalin model of pain. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 506.1±53.0 °C at 760 mmHg |
| Melting Point | 87-88ºC |
| Molecular Formula | C17H17N5O |
| Molecular Weight | 307.350 |
| Flash Point | 259.9±30.9 °C |
| Exact Mass | 307.143311 |
| PSA | 63.91000 |
| LogP | 2.15 |
| Vapour Pressure | 0.0±1.3 mmHg at 25°C |
| Index of Refraction | 1.640 |
| Storage condition | 2-8℃ |
| Risk Phrases | 22 |
|---|